KIADIS PHARMA NV

Balance sheet

Assets 19,000,000  EUR 33,000,000  EUR 10,000,000  EUR 10,000,000  EUR
Goodwill 4,000,000  EUR 4,000,000  EUR 4,000,000  EUR 4,000,000  EUR
Current Assets 15,000,000  EUR 29,000,000  EUR 6,000,000  EUR 6,000,000  EUR
Cash And Cash Equivalents 15,000,000  EUR 29,000,000  EUR 6,000,000  EUR 6,000,000  EUR
Liabilities 139,000,000  EUR 129,000,000  EUR 88,000,000  EUR 86,000,000  EUR
Equity 105,000,000  EUR 99,000,000  EUR 71,000,000  EUR 66,000,000  EUR
Common Stock 105,000,000  EUR 99,000,000  EUR 68,000,000  EUR 63,000,000  EUR
Treasury Stock 0  EUR 0  EUR 3,000,000  EUR 3,000,000  EUR
Current Liabilities 18,000,000  EUR 16,000,000  EUR 12,000,000  EUR 10,000,000  EUR
Accounts Payable 1,000,000  EUR 1,000,000  EUR 0  EUR 0  EUR
Short/Current Long Term Debt 17,000,000  EUR 15,000,000  EUR 12,000,000  EUR 10,000,000  EUR
Long Term Debt 16,000,000  EUR 14,000,000  EUR 5,000,000  EUR 10,000,000  EUR

Key figures

On 31/12/16 the equity of company KIADIS PHARMA NV was 105,000,000 EUR.  As its assets have been 19,000,000 EUR the equity ratio is 552.63 %.  As the equity ratio is very high, the risk of selective default is lower than average. An investment in bonds of this company can be recommended, though first a deeper analysis of the current financial situation of KIADIS PHARMA NV should take place.

NL0011323407: KIADIS PHARMA NV EO -,10
The book value per share of KIADIS PHARMA NV EO -,10 (ISIN: NL0011323407) is 0. Current market price is 1.7510 Euro. As the current market price is higher than the book value per share, this financial instrument might not be a promising investment. Please check whether there are other factors like goodwill that justify this valuation.

Ticker Symbols

K3P.BE

K3P.F

KDS.AS

KDS.BR

KDS.NX